Form 4 for ABT Abbott Laboratories
Accepted 2022-02-25 00:00:00 ET · period of report 2022-02-24 · accession 0001415889-22-001883 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-25 | 2022-02-24 | ABT | McKinstry Nancy | Dir | S - Sale+OE | $116.43 | -1,614 | 31.8K | -5% | -$187.9K |
| D | 2022-02-25 | 2022-02-24 | ABT | McKinstry Nancy | Dir | M - OptEx | $29.84 | +6,280 | 33.4K | +23% | +$187.4K |
| D | 2022-02-25 | 2022-02-24 | ABT | McKinstry Nancy | Dir | M - OptEx | $0.00 | -6,280 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-02-24 | S | D | 1,614 | $116.43 | 31,805 | D | — | — | |
| 2 | Common | Common shares without par value | 2022-02-24 | M | A | 6,280 | $29.84 | 33,419 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2022-02-24 | M | D | 6,280 | $0.00 | 0 | D | $29.84 · 2012-04-27 to 2022-04-26 | 6,280 Common Shares | (F1) Stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |